By Alexander Gaffney, RF News Editor
Guidance documents, as the US Food and Drug Administration (FDA) often reminds industry, are not legally binding entities. Rather, they represent insight into regulators’ current best thinking on a particular subject, giving companies the opportunity to make compliant their operations and avoid any regulatory headaches.
Pharmacy’s Penicillin Manufacturing Problems Relate to Recently-Released Guidance Document.